Latest Ratings for GPN Date Firm Action From To Feb 2022 Morgan Stanley Maintains Equal-Weight Feb 2022 Rosenblatt Maintains Buy Feb 2022 Raymond James Maintains Outperform View More Analyst Ratings for GPN View the Latest Analyst Ratings read more
PTC Therapeutics partners with Novartis for its PTC518 Huntington’s program in a deal valued up to $2.9 billion, including milestones and royalties. read more
The success of Nvidia in recent years could have been much different if co-founder and CEO Jensen Huang took a job he was offered in 2013. read more
Marvell Technology and AWS announced a 5-year expanded partnership to drive advancements in accelerated data solutions, with Marvell’s semiconductor portfolio and AWS’s EDA solutions. read more
Bitcoin‘s (CRYPTO: BTC) transition from a decentralized digital asset to one dominated by institutional players has introduced a new set of risks. read more
Silicon Valley’s top leaders, including Steve Jobs, Sam Altman, and Elon Musk, share their experiences with psychedelics, from personal transformation to innovation. read more
Ero Copper shares climb as Tucumã project ramps up, Goldman Sachs expects strong production & EBITDA growth. Analyst initiates buy rating with $19 price target. read more
Stellantis announced that its CEO, Carlos Tavares, has resigned. read more
A study finds that anti-obesity medications may help reduce alcohol consumption, with nearly half of participants in weight loss programs reporting decreased use. read more
Latest Ratings for SFIX Date Firm Action From To Mar 2022 Morgan Stanley Maintains Equal-Weight Mar 2022 Canaccord Genuity Maintains Buy Mar 2022 Stifel Maintains Hold View More Analyst Ratings for SFIX View the Latest Analyst Ratings read more